Peer Review History
Original SubmissionJuly 10, 2021 |
---|
PONE-D-21-22539Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 PandemicPLOS ONE Dear Dr. Watanabe, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 15 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ismaeel Yunusa, PharmD, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript adds an increasing list of similar researches on psychological predictors of covid-19 vaccination intentions, and the results are not surprisingly consistent with what others have been found, but still it's good to see the authors collected two new samples on vaccine intentions (the college undergrads and the online workers). My main questions are: 1) There is no justification of the representativeness of the sample for their surveys relative to the general US populations, which makes it hard to assess whether the study is reliably capturing the attitudes of the general population toward covid-19 vaccination. The sample size for each of the two samples seemed too small to be much representative. 2) There is a concern that some of the reported statistical analyses may not be valid, due to likely violations of the assumptions of a linear regression model. This is especially for the college student sample. If the students surveyed have certain clustering effect, e.g., some are in the class, in the same department or program, then the data is not independent. If this is the case, some kind of linear mixed model with random effects is more appropriate than the multiple regression model that the authors employed. Reviewer #2: Thank you for the opportunity to review this manuscript. I appreciate the amount of work that has been put into this study; the authors should be commended for their efforts to study the psychological roots of vaccine hesitancy during the current pandemic. Below are my concerns •I have major problems with the way the data are presented, and the manuscript is written and I recommend major revision to have a more concise manuscript with a clear flow and more clear conclusion. I include a couple of examples on issues that need to be further clarified below. •I do not see any benefit of splitting the study samples into 1& 2, and if there was, it was not made clear in the presentation of the study. I understand that sample 2 was needed to have a more age-diverse sample, but why not combine them? If it was because you expected differences between the two samples, then explain why you would put this assumption? On what basis? This needs to be explained or changed. There are also differences in the questions asked to each sample which were not explained; on what basis did the author choose to do so? Any benefits? Wouldn't that increase variability of the results among the samples? •The manuscript reads more like a thesis than a concise manuscript it lacks “straight to the point” presentation of data and clear conclusions. I recommend rewriting the manuscript, especially the introduction, which should be one coherent piece of work, also the methods and the results. The conclusion in the abstract will need reconsideration as it starts with a vague sentence and does not give any concise conclusion •The questionnaires used are very lengthy, and despite the attention checks the authors have described, no information has been provided regarding how many participants were excluded due to failing the attention check; they only report a general total number of 38 excluded for different reasons for sample one and same regarding sample 2 were 172 were excluded for several reasons. •Line 85: "Whereas previous research has examined attitudes about vaccination 86 for diseases that are hypothetical (e.g., Haase et al., 2015; Jolley & Douglas, 2017), relatively 87 low-threat (e.g., seasonal flu; Zhang et al., 2010) or mostly eradicated in the U.S. (e.g., Dubé et 88 al., 2015), the present research investigates vaccination intentions during a unique period of uncertainty involving a highly contagious disease when effective treatments or vaccines had not yet been developed." The authors should report the published evidence on vaccine intentions in the COVID-19 era •The authors mention that” Sample 1 included 346 undergraduate students from the University of Illinois at Urbana183 Champaign recruited in exchange for course credit” Can you elaborate more on what do you mean here? Were the participants given a choice to join? How did you guarantee that participants were aware that their participation is optional? •The discussion section can be improved by highlighting the take-home message from the study and take the reader through what has been done and what does that mean rather than displaying the results. As an example in line 418: "knowledge, no prior study has simultaneously measured vaccine attitudes for both a hypothetical disease and a real disease during a pandemic. Measuring both together and determining which variables predict well across measures is important, as it provides context for past work and can bolster confidence in how well past research applies to actual intentions during a crisis period…… The current work shows that factors associated with immunization decisions for a hypothetical disease are also mostly predictive of real vaccination intentions." I do not see the point here? Can you elaborate on the reasons behind studying vaccine attitudes for both hypothetical disease and a real disease during a pandemic? Not at any point of the manuscript, this was discussed clearly •The tables are confusing with too many details; I suggest editing them to highlight the most important message from each table and move any unnecessary information to the supplementary file. •In the supplementary file, Why was the attention check different between samples 1 &2? What did you base this on? For Sample 1, the following item was asked prior to the demographics questionnaire: •Thank you for your responses. You are almost finished with this study. Before answering a few questions about yourself, we have one last question. Do you think we should include your responses in our study? That is, did you take the study seriously and respond thoughtfully? Your credit assignment for this study does not depend on your response to this question. [Yes, I responded thoughtfully / No, I did not respond thoughtfully.] Sample 2 Only For Sample 2, the following item was embedded in the optimism bias measure: If you are reading this, please select 67 on this sliding scale. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 Pandemic PONE-D-21-22539R1 Dear Dr. Watanabe, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ismaeel Yunusa, PharmD, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your contributions! Reviewers' comments: |
Formally Accepted |
PONE-D-21-22539R1 Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 Pandemic Dear Dr. Watanabe: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ismaeel Yunusa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .